Nanopharm: Valve Types & Container Systems in pMDIs with Salmeterol
Explore Nanopharm’s study on the impact of valve types and container closure systems in pMDIs. Focus on formulations with Salmeterol Xinafoate and how they perform under stressed conditions.
The Role of In Silico Regional Deposition Modelling and Pharmacokinetic Profiling in the Development of a Generic Tiotropium Dry Powder Inhaler
Nanopharm explores In Silico methods in the development of a Generic Tiotropium Dry Powder Inhaler (DPI). Learn how drug absorption is impacted.
In Vitro and In Silico Comparison of Indacaterol and Glycopyrrolate Pulmonary Deposition between a Single-Unit Dose and a Multi-Unit Dry Powder Inhaler
In-depth study by Nanopharm on In Vitro and In Silico comparison of Indacaterol and Glycopyrrolate in single-unit and multi-unit DPIs for COPD treatment.
Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug
Nanopharm explores annealing in micronized DPIs for drug development. Focus on molecular changes and SFE in Dry Powder Inhaler formulations.
Alternative regulatory path for generic Respiratory Products
Explore Nanopharm’s SmartTrack, an alternative solution for FDA approval of generic inhalation drug delivery products.
Trade Marks Registration Certificate for Nanopharm Ltd
Discover Nanopharm’s leading role in pharmaceutical research, specializing in OINDP, nasal, and inhaled pharmaceutical solutions.
Characterizing Nasal Suspensions for Regulatory and Scientific Purposes
Explore Nanopharm’s in-depth research on particle size and its role in in vitro bioequivalence for nasal drug delivery. Discover how particle sizing impacts regulatory compliance and drug efficacy.
Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers
Explore Nanopharm’s in-depth in vitro study on dry powder inhalers (DPIs). Learn how Computational Fluid Dynamics and Particle Size Distribution contribute to device performance and comparability.
The Influence of Secondary Processing on the Structural Relaxation Dynamics of Fluticasone Propionate
Nanopharm explores structural dynamics of Fluticasone Propionate in DPIs. Focus on APSD in Dry Powder Inhaler formulations.
Advanced microscopy techniques to assess solid-state properties of inhalation medicines
Unveil Nanopharm’s expertise in advanced microscopy for OINDP. Explore solid-state analysis and its impact on inhalation medicines, including dry powder inhalers.
